CN105616536A - Traditional Chinese medicine liniment for treating leukoderma - Google Patents
Traditional Chinese medicine liniment for treating leukoderma Download PDFInfo
- Publication number
- CN105616536A CN105616536A CN201610034184.2A CN201610034184A CN105616536A CN 105616536 A CN105616536 A CN 105616536A CN 201610034184 A CN201610034184 A CN 201610034184A CN 105616536 A CN105616536 A CN 105616536A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- liniment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 103
- 229940040145 liniment Drugs 0.000 title claims abstract description 44
- 239000000865 liniment Substances 0.000 title claims abstract description 44
- 206010024380 Leukoderma Diseases 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims description 43
- 241000628997 Flos Species 0.000 claims description 31
- 239000000706 filtrate Substances 0.000 claims description 24
- 230000001476 alcoholic effect Effects 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 238000007789 sealing Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 24
- 210000004185 liver Anatomy 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 20
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 44
- 210000003734 kidney Anatomy 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 206010047642 Vitiligo Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 206010025421 Macule Diseases 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 11
- 206010037844 rash Diseases 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 208000010201 Exanthema Diseases 0.000 description 9
- 201000005884 exanthem Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 206010040882 skin lesion Diseases 0.000 description 9
- 231100000444 skin lesion Toxicity 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 5
- 238000011047 acute toxicity test Methods 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000002747 voluntary effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SBAFZBVZGFUKPK-MVAXXSNXSA-N Carthamone Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(C(O)=CC1=O)=O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 SBAFZBVZGFUKPK-MVAXXSNXSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- -1 monoterpene phenols Chemical class 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical compound CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000130784 Arnebia euchroma Species 0.000 description 1
- 241001050829 Arnebia guttata Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- QWVMSYBGKWZIIE-RDFNRINOSA-N Flavochrome Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CCCC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CCCC3(C)C)C QWVMSYBGKWZIIE-RDFNRINOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 241001446509 Psoralea Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000159213 Zygophyllaceae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000001591 beta-pinene derivatives Chemical class 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- QWVMSYBGKWZIIE-FZKBJVJCSA-N flavochrome Chemical compound O1C2(C)CCCC(C)(C)C2=CC1C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1C(C)=CCCC1(C)C QWVMSYBGKWZIIE-FZKBJVJCSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000020072 grain neutral spirit Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 208000010484 vulvovaginitis Diseases 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine preparation, and particularly relates to a traditional Chinese medicine liniment for treating leukoderma. The liniment is characterized by being prepared from the following medicinal raw materials in parts by weight: 18-30 parts of tribulus terrestris, 9-18 parts of fructus psoraleae, 8-12 parts of processed polygonum multiflorum, 6-15 parts of angelica sinensis, 2-6 parts of safflower carthamus and 2-10 parts of licorice root. The traditional Chinese medicine liniment has the beneficial effects of dispelling wind, drying dampness, nourishing blood, promoting blood circulation and soothing the liver, can be used for reversing the skin color of a leukoderma affected part and remarkably alleviating extension of the affected area, can cure mild cases and control serious cases, has no allergic response, has toxic or side effect, can be used for a long time since the raw materials are easily available and low in cost, and can be expected to become a necessary medicine for patients with leukoderma.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, namely one treats leukodermic Traditional Chinese medicine liniment.
Background technology
Vitiligo is a kind of chronic, intractable depigmentation dermatoses, it is apt to occur in exposure portion and affects attractive in appearance, it is characterized by that the polytype white patch varying in size, coming in every shape occurs in skin, the generation of skin lesion place melanocyte slows down or disappears, belong to the category of the traditional Chinese medical science " vitiligo is sick ", " leucoderma ", be that one easily diagnoses and dermatosis difficult to treat. Both at home and abroad its research being deepened continuously at present, have pharmacotherapy, physiotherapy and surgical treatment, but how inconspicuous therapeutic effect is, and treatment time is longer, costly, what have also has toxic and side effects. Therefore, finding a kind of evident in efficacy, side effect is little, and raw material is easy to get, the leukodermic medicine for the treatment of with low cost, becomes the target that medical research personnel generally pursue.
Summary of the invention
It is an object of the invention to provide a kind of definite curative effect that vitiligo is had, and raw material is easy to get, with low cost, side effect is little, can the Traditional Chinese medicine liniment of life-time service.
Above-mentioned purpose is realized by techniques below scheme: provide one to treat leukodermic Traditional Chinese medicine liniment, it is characterized in: described Traditional Chinese medicine liniment is made up of crude drug and the solvent of following weight portion: crude drug Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, solvent is the alcoholic solution 650 1000 parts of 25% 30%.
Described Traditional Chinese medicine liniment preparation method is: the crude drug of said ratio amount was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, loads in vial, adds the solvent of said ratio amount, cover bottle cap sealing, soaking 3, filter to obtain filtrate, residue squeezes to obtain pressed liquor, pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Described crude drug adds Radix Sophorae Flavescentis 58 parts, Cortex Phellodendri 46 parts, Fructus Chaenomelis 34 parts.
The preparation method of above-mentioned Traditional Chinese medicine liniment is: by Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, Radix Sophorae Flavescentis 58 parts, Cortex Phellodendri 46 parts, Fructus Chaenomelis 34 parts, was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, loaded in vial, add the solvent of said ratio amount, cover bottle cap sealing, soak 3, filtering to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Described crude drug adds Radix Arnebiae (Radix Lithospermi) 57 parts, Radix Curcumae 36 parts, Radix Et Rhizoma Nardostachyos 25 parts.
The preparation method of above-mentioned Traditional Chinese medicine liniment is: by Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, Radix Arnebiae (Radix Lithospermi) 57 parts, Radix Curcumae 36 parts, Radix Et Rhizoma Nardostachyos 25 parts, was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, loaded in vial, add the solvent of said ratio amount, cover bottle cap sealing, soak 3, filtering to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Described crude drug adds pit 47 parts, Fructus Alpiniae Oxyphyllae 35 parts, Flos Trollii 35 parts.
The preparation method of above-mentioned Traditional Chinese medicine liniment is: by Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, pit 47 parts, Fructus Alpiniae Oxyphyllae 35 parts, Flos Trollii 35 parts, was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add the solvent of said ratio amount, cover bottle cap sealing, soak 3, filter to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stands 24 hours, take the supernatant, obtain liniment.
The invention has the beneficial effects as follows: by expelling wind and removing dampness, replenishing and activating blood, suppressing the hyperactive liver dispelling wind, vitiligo affected part color reversal can be made, and can substantially slow down the extension suffering from face, mild can heal, and serious symptom is controlled, not yet finds anaphylaxis and toxic and side effects, and raw material is easy to get, with low cost, it is possible to life-time service, it is expected to become the required medicines of patients with vitiligo.
Detailed description of the invention
The present invention is characterized by: Fructus Tribuli, Fructus Psoraleae, Radix Polygoni Multiflori Preparata, Radix Angelicae Sinensis, Flos Carthami, Radix Glycyrrhizae is pulverized and makes liniment, for leukodermic treatment. Embodiment is a lot, below only for four embodiments:
The first embodiment: take Fructus Tribuli 18 30 parts by weight, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, the alcoholic solution 650 1000 parts of 25% 30%. Preferred Fructus Tribuli 24g, Fructus Psoraleae 13g, Radix Polygoni Multiflori Preparata 10g, Radix Angelicae Sinensis 10 parts of g, Flos Carthami 4g, Radix Glycyrrhizae 6g, and said medicine was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add the alcoholic solution 670ml of 25% 30%, cover bottle cap sealing, soak 3, filtering to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Using method is: embrocate affected part, 2 times on the one.
Taboo item: during medication, edible raw and cold, greasy, the maror of taboo; Forbid taking orally.
The second embodiment: take Fructus Tribuli 18 30 parts by weight, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, Radix Sophorae Flavescentis 58 parts, Cortex Phellodendri 46 parts, Fructus Chaenomelis 34 parts, the alcoholic solution 650 1000 parts of 25% 30%. Preferred Fructus Tribuli 24g, Fructus Psoraleae 13g, Radix Polygoni Multiflori Preparata 10g, 10 parts of g of Radix Angelicae Sinensis, Flos Carthami 4g, Radix Glycyrrhizae 6g, Radix Sophorae Flavescentis 6g, Cortex Phellodendri 5g, Fructus Chaenomelis 3.5g, and said medicine was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add the alcoholic solution 810ml of 25% 30%, cover bottle cap sealing, soak 3, filtering to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment 110g.
Using method is: embrocate affected part, 2 times on the one.
Taboo item: during medication, edible raw and cold, greasy, the maror of taboo; Forbid taking orally.
The third embodiment: take Fructus Tribuli 18 30 parts by weight, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, Radix Arnebiae (Radix Lithospermi) 57 parts, Radix Curcumae 36 parts, Radix Et Rhizoma Nardostachyos 25 parts, the alcoholic solution 650 1000 parts of 25% 30%. Preferred Fructus Tribuli 24g, Fructus Psoraleae 13g, Radix Polygoni Multiflori Preparata 10g, 10 parts of g of Radix Angelicae Sinensis, Flos Carthami 4g, Radix Glycyrrhizae 6g, Radix Arnebiae (Radix Lithospermi) 6g, Radix Curcumae 4.5g, Radix Et Rhizoma Nardostachyos 3.5g, and said medicine was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add the alcoholic solution 810ml of 25% 30%, cover bottle cap sealing, soak 3, filtering to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Using method is: embrocate affected part, 2 times on the one.
Taboo item: during medication, edible raw and cold, greasy, the maror of taboo; Forbid taking orally.
4th kind of embodiment: take Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts by weight, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, pit 47 parts, Fructus Alpiniae Oxyphyllae 35 parts, Flos Trollii 35 parts, the alcoholic solution 650 1000 parts of 25% 30%. Preferred Fructus Tribuli 24g, Fructus Psoraleae 13g, Radix Polygoni Multiflori Preparata 10g, 10 parts of g of Radix Angelicae Sinensis, Flos Carthami 4g, Radix Glycyrrhizae 6g, pit 6g, Fructus Alpiniae Oxyphyllae 4g, Flos Trollii 4g, and said medicine was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add the alcoholic solution 810ml of 25% 30%, cover bottle cap sealing, soak 3, filtering to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Using method is: embrocate affected part, 2 times on the one.
Taboo item: during medication, edible raw and cold, greasy, the maror of taboo; Forbid taking orally.
Experimental conditions
1. acute toxicity test:
1.1 Rabbits with Acute toxicity tests: adult healthy white rabbit 24, about body weight 2kg, male and female half and half. Excipient: the alcoholic solution of 25% 30%. Rabbit is randomly divided into 6 groups by body weight, sex, often group 4. Consider vitiligo medication process also exists skin complete and two kinds of situations of skin injury, therefore carried out intact skin experiment and damaged skin two kinds of experiments of experiment. Every kind of experiment divides equally three groups, it may be assumed that high dose group, low dose group and excipient control group. Intact skin tests 24h Na before test2S gelatinized corn starch is by all back part of animal spinal column both sides unhairing. After damaged skin experiment adopts same method unhairing and sterilizes, then with blade, skin is scratched, with oozing of blood for degree. Low dosage is set to 1.25ml/kg, and high dose is set to 5ml/kg, 2 times/d, is applied to depilation district, and surface covers nonirritant gauze, with immobilization with adhesive tape, within second day, removes left drug with warm water.
1.2 overviews: administration is at once to the 7th day, observe systemic toxicity profiles performance and the death condition of animal every day, including skin, hair, eyes, mucosa, extremity activity with or without ANOMALOUS VARIATIONS, observe animal breath, central nervous system shows with or without poisoning symptom simultaneously, and the weight of animals change before and after administration. Experimental result is in Table 1, table 2, table 3.
Table 1 intact skin animal pattern the acute toxicity tests
Table 2 damaged skin animal pattern the acute toxicity tests
Table 3 acute toxicity test rabbit body weight change (kg,)
| Group | Dosage (ml kg) | Before medication | 7d after medication |
| Intact skin | 0 | 2.08��0.13 | 2.28��0.17 |
| Low dose group | 1.25 | 2.05��0.13 | 2.23��0.10 |
| High dose group | 5.00 | 2.03��0.10 | 2.25��0.21 |
| Damaged skin | 0 | 1.98��0.19 | 2.20��0.24 |
| High dose group | 1.25 | 2.08��0.05 | 2.28��0.05 |
| Low dose group | 5.00 | 2.05��0.17 | 2.30��0.22 |
From table 1, table 2, when intact skin and damaged skin animal pattern dosage are up to clinical equivalent amount 40 times, animal is still without dead, observing each treated animal and ANOMALOUS VARIATIONS all do not occur, general activity is normal, and behavior is active, hair light, diet, defecation are without exception, mouth, eye, nose secretions without exception, and mucosa is without hyperemia; From table 3, before and after rabbit administration, body weight is without significant change. Illustrating that this medicine is nontoxic, the clinical application amount of this medicine is the dosage of a safety.
1.3 histopathologic examinations: the observation period terminates, taking each group of Some Animals, to knock head lethal, take medicine area skin and carry out histopathologic examination, result shows, normal group animal skin horny layer, epidermal area and skin corium structural integrity, and damaged skin treated animal is the stratified squamous epithelium of keratinization, it was shown that this liniment high and low dose group, after rabbit medication, skin compares unknown significance difference with matched group.
2. comprehensively analyze:
According to relevant theory of Chinese medical science, leukodermic medicine typing mainly has following three aspects: one, and the heresy of rheumatism is fought in skin, and QI and blood is lost smooth, caused by the not flourish skin of blood; Its two, because feelings will is hindered or because of leucoderma charming appearance and behaviour depressed emotion, liver imbalance is smooth, qi-blood disharmony, caused by failure of skin and muscle to be nourished; Its three, owing to the primary disease persistent period is permanent, prolonged illness damages, and causes caused by caused by liver and kidney deficiency. Based on above-mentioned cognition, through substantial amounts of experiment screening, define this regimen. Prescription is divided into main formula and subsidiary formula two parts, and its main formula can be independently operated, subsidiary formula and can use with main formula combination.
3. the main formula crude drug property of medicine is analyzed:
Fructus Tribuli, derives from the dry mature fruit of zygophyllaceae plant Fructus Tribuli TribulusterrestrisL.. Fatty oil and a small amount of volatile oil, tannin, resin, Alkaloid etc. Nature and flavor are pungent, bitter, and tepor is slightly poisonous, returns Liver Channel. There is suppressing the hyperactive liver dispelling wind, effect of dispelling pathogenic wind for improving eyesight. It is usually used in treatment excessive rising of liver-YANG, has a dizzy spell, wind heat is attacked, cataract, rubella Pruritus. Fructus Tribuli decocting liquid has reduction blood glucose effect; Water extract has anti-allergic effects. According to another report, Fructus Tribuli extract and cream, paraffin, glycerol make external preparation, treatment vulvovaginitis, acne, herpes, varicosis etc., have antiinflammatory, antiviral, antibacterial action (external botanical medicine fascicle, 2001,6:275). The experiment proved that, the Fructus Tribuli tincture of 25% is very micro-to the therapeutic effect of vitiligo disease, and cure rate is less than 2%.
Fructus Psoraleae, derives from the dry mature fruit of legumes psoraleae PsoraleacorylifoliaL.. The property of medicine: acrid, bitter, warm, returns kidney, spleen channel. Containing Coumarins, flavonoid and monoterpene phenols. There is warming the kidney to activate YANG, helping inspiration to relieve asthma, warming spleen and stopping diarrha effect; External pathogenic wind expelling speckle dispelling. For insufficiency of kidney-YANG, impotence and seminal emission, enuresis frequent micturition, chills and pain of the waist and kness, suffer from a deficiency of the kidney and breathe heavily, Diarrhoea. Having pass made, patients with vitiligo is had certain therapeutical effect by the psoralea tincture of 75%, but this tincture sensitization is relatively strong, can produce the untoward reaction such as redness, blister.
Radix Polygoni Multiflori Preparata, for the Preparation process product of Radix Polygoni Multiflori. Mix steaming with Semen sojae atricolor liquor, after solarization, become black, claim Radix Polygoni Multiflori Preparata, its property of medicine: bitter, sweet, puckery, tepor, return liver, kidney channel. There is invigorating the liver and kidney, benefiting essence-blood, crow beard and hair, bone and muscle strengthening, change effect of turbid blood fat reducing. For blood deficiency and yellow complexion, vertigo and tinnitus, early whitening of beard and hair, soreness of the waist and knees, numb limbs and tense tendons, bleeding not during menses, hyperlipemia is demonstrate,proved. Clinical research in modern age finds, Radix Polygoni Multiflori Preparata and Radix Rehmanniae Preparata, Radix Angelicae Sinensis are dipped in grain neutral spirit and treat poliosis effectively (Shandong journal of Chinese medicine, 1983,4:41).
Flos Carthami, derives from the tubular corolla of feverfew Flos Carthami CarthamustinctoriusL.. Containing carthamone, neocarthamin, Carthamus yellow and flavochrome, separately containing safflower oil. The property of medicine: pungent, warm, GUIXIN, Liver Channel. There is promoting blood circulation to restore menstrual flow, effect of dissipating blood stasis hemostasis. For amenorrhea, dysmenorrhoea, lochia, obstruction of qi in the chest and cardialgia, the stagnant stomachache of the stasis of blood, breast side of body twinge, injury from falling down, skin infection swells and ache. According to relevant information: coronary heart diseases and angina pectoris is had by the Flos Carthami injection of 50% controls effect significantly.
Radix Angelicae Sinensis, for the dry root of umbelliferae angelica Angellicasinensis (Oliv.) Diels. Containing neutral oil compositions such as australene, nopinenes, containing to acid-soluble oil composition, organic acid, aminoacid, vitamin etc. such as methylbenzyl alcohol, 5 methoxyl group 2,3 xylenols. The property of medicine: sweet, pungent, warm. Return liver, the heart, spleen channel. There is replenishing and activating blood, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation. Pharmacological action: Radix Angelicae Sinensis volatile oil can the excitation to uterus to antiadrenergic drug pituitrin or histamine. Eumenol has notable expansion isolated guinea pig coronary effect, increases coronary flow. Expeirmental myocardial ischemia is had obvious protective function by Radix Angelicae Sinensis neutral oil. To Mouse oral Radix Angelicae Sinensis infusion, hemoglobin and erythrocytic generation can be remarkably promoted. Clinical research: angelica fluid injects in sensitive spot or neuroganglion, or escalated dose is quiet pushes away or quiet, treatment thromboangiitis obliterans, suffering limb is had pain relieving, blood circulation promoting, improves skin temperature, stop necrosis to occur, develop, the effect such as wound healing (new medicine and pharmacology magazine, 1977,11:35).
Radix Glycyrrhizae, for glycyrrhizic legume GlicyrrhizaualensisFisch., the dry root of Glycyrrhiza inflata Bat. GlicyrrhizainflataBat. Glycyrrhiza glabra L. GlicyrrhizaglabraL. and rhizome. The property of medicine: sweet, flat. GUIXIN, lung, spleen, stomach warp. There is invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, relieving spasm to stop pain, effect of coordinating the actions of various ingredients in a prescription. It is usually used in weakness of the spleen and stomach, too fat to move sore, relaxes drug toxicity, strong.
Visible, above-mentioned Six-element medicine, Fructus Tribuli is monarch drug, has suppressing the hyperactive liver dispelling wind, effect of expelling wind and removing dampness, for treating the principal agent of leucoderma disease. Fructus Psoraleae, Radix Polygoni Multiflori Preparata return liver, kidney channel, have effect of nourishing the liver and kidney, benefiting essence-blood, and for ministerial drug, meaning has two: one, can assist a ruler in governing a country monarch drug and strengthen treatment vitiligo primary symptom. Its two, if the primary disease persistent period is permanent, prolonged illness damages, and causes caused by liver and kidney deficiency, and Fructus Psoraleae now, Radix Polygoni Multiflori can be held concurrently again treating the liver kidney yin deficient syndrome. Assistant, with Radix Angelicae Sinensis, Flos Carthami, is enriched blood, is invigorated blood circulation, and nourishes skin. Radix Glycyrrhizae QI invigorating and in, coordinating the actions of various ingredients in a prescription, alleviate toxicity, for adjuvant. All medicines share, and play expelling wind and removing dampness, suppressing the hyperactive liver dispelling wind, QI and blood regulating altogether, nourish skin, mediation feelings will, take good care of internal organs, dispel or suppress the merit of white macula.
4. main formula clinical experiment:
With reference to the criterion of therapeutical effect of " clinical disease diagnosis is according to curing improvement standard " (the Sun Chuanxing work People's Medical Officer Press second edition), the concrete curative effect of this liniment is divided into following three grades: cure: skin color recovers normal completely, does not recur; Effective: to have pigment island to be formed in white macula skin lesion, skin color 80% recovers normal, occurs without recurrence and new rash; Take a turn for the better: having pigment island to be formed in white macula skin lesion, skin color 50% recovers normal, occur without recurrence and new rash; Invalid: vitiligo symptom has no to disappear, and white macula is not any change.
Since 2011, in local multiple hospitals, when patient is voluntary, vitiligo disease 70 example betiding different parts is controlled in examination, and medication 15 days is a course for the treatment of, and all three courses for the treatment of of treatment, statistical result is table 1 such as:
Table 1
In above-mentioned 70 example patients with vitiligo, trick portion patient, overall clinical efficacy rate is minimum, and analysis reason is trick face is human body distal portion, and blood circulation is poor, and drug absorption is undesirable and causes, if long-term, intermittent treatment can be adhered to, it is expected to obtain better effect.
5. the subsidiary formula 1 crude drug property of medicine is analyzed:
Radix Sophorae Flavescentis is the dry root of leguminous plant Radix Sophorae Flavescentis SophoraflavescensAit.. Nature and flavor: bitter, cold. GUIXIN, liver, stomach, large intestine, bladder warp. Function with cure mainly: heat clearing and damp drying, parasite killing, diuresis. For hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies addiction leprosy; External treatment trichomonal vaginitis.
Cortex Phellodendri is the dry bark of rutaceae wampee PhellodendronchinenseSchneid.. Nature and flavor: bitter, cold. Return kidney, bladder warp. Function with cure mainly: heat clearing and damp drying, pathogenic fire purging except steam, detoxification sore treatment. For damp-heat dysentery, yellow cellulitis dark coloured urine, leukorrhagia pudendal pruritus, the puckery pain of pyretic stranguria, beriberi flaccidity, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema eczema. Stir-baked CORTEX PHELLODENDRI with salt solution nourishing YIN to lower pathogenic fire. For hyperactivity of fire caused by deficiency of YIN, night sweat hectic fever due to YIN-deficiency.
Fructus Chaenomelis is the dry almost ripe fruit of rosaceous plant chaenomeles lagenaria Chaenomelesspeciosa (Sweet) Nakai. Nature and flavor: acid, temperature. Return liver, spleen channel. Function with cure mainly: relaxing muscles and tendons and activating QI and blood in the collateral, stomach function regulating removing dampness. For arthralgia chiefly caused by damp pathogen contracture, waist knee joint acid weight pain, heat-damp in summer is vomited and diarrhoea, and has a cramp spasm and pain, beriberi edema. In modern Application often using Fructus Chaenomelis as anti-acne, Anti-allergic cosmetic raw material.
Visible, above-mentioned three taste medicines, Radix Sophorae Flavescentis, Cortex Phellodendri nature and flavor bitter cold, relatively heat clearing and damp drying, dispels damp, is equipped with acid, the warm nature medicine Fructus Chaenomelis alleviation property of medicine, and can dispel redness, and removing dampness sore alleviates the other medicines sensitivity response to skin. This subsidiary formula 1 is share with main formula, relatively the treatment vitiligo initial stage, and damp invades skin, checks mechanism of qi, caused by the not flourish skin of blood.
6. main formula adds subsidiary formula 1 clinical trial
With reference to the criterion of therapeutical effect of " clinical disease diagnosis is according to curing improvement standard " (the Sun Chuanxing work People's Medical Officer Press second edition), the concrete curative effect of this liniment is divided into following three grades: cure: skin color recovers normal completely, does not recur; Effective: to have pigment island to be formed in white macula skin lesion, skin color 80% recovers normal, occurs without recurrence and new rash; Take a turn for the better: having pigment island to be formed in white macula skin lesion, skin color 50% recovers normal, occur without recurrence and new rash; Invalid: vitiligo symptom has no to disappear, and white macula is not any change.
Since 2012, in local multiple hospitals, when patient is voluntary, extract patient 90 example, wherein course of disease patient 30 example within 3 months, is ill initial stage, the course of disease patient of 3 months to 2 years 28 example, it is ill mid-term, 32 examples of the course of disease more than 2 years, is the ill later stage. Medication 15 days is a course for the treatment of, all three courses for the treatment of of treatment, and its result is added up such as table 2:
Table 2
Upper table data are visible: the overall clinical efficacy rate at initial stage, apparently higher than mid-term, later stage, illustrates that main formula adds subsidiary formula 1 and the initial stage patient that the course of disease is shorter is acted on substantially.
7. the subsidiary formula 2 crude drug property of medicine is analyzed:
Radix Arnebiae (Radix Lithospermi) is comfrey lithospermum euchromum Royle Arnebiaeuchroma (Royle) Johnst. or the dry root of arnebia guttata Bunge Arra coffee aBunge. Nature and flavor: sweet, salty, cold. GUIXIN, Liver Channel. Function with cure mainly: clearing away heat and cooling blood, promoting blood circulation and detoxication, rash speckle removing. Containing for heat in blood poison, macule purple is black, measles without adequate eruption, skin infection, eczema, burn due to hot liquid or fire.
Radix Curcumae is the dried root of zingiberaceous plant RADIX CURCUMAE CurcumazvenyujinY.H_ChenetC.Ling, Rhizoma Curcumae Longae CurcumalongaL., Guangxi art CurcumakwangsiensisS.G.LeeetC.F.Liang or Rhizoma Curcumae CurcumaphaeocauLisVal.. Nature and flavor: pungent, bitter, cold. The heart, Liver Channel. Function with cure mainly: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, clear away heart-fire removing heat from blood, promoting the function of the gallbladder to alleviate jaundice. Coercing twinge for breast, obstruction of qi in the chest and cardialgia, amenorrhea dysmenorrhea, distending pain of the breast, calentura coma, epilepsy is gone mad, and heat in blood tells nosebleed, jaundice dark coloured urine.
Radix Et Rhizoma Nardostachyos is the dry root and rhizome of Valerianaceae plant Radix Et Rhizoma Nardostachyos NardostachysjatamansiDC.. Nature and flavor: acrid, sweet, warm. Return spleen, stomach warp. Function: regulating QI to relieve pain, relieving stagnation and activating the spleen, external damp eliminating is subsided a swelling. For distension and fullness in the abdomen, inappetence, vomiting; Toothache, beriberi toxic swelling are controlled in external.
Visible, above-mentioned three taste medicines, Radix Arnebiae (Radix Lithospermi) enters the heart, Liver Channel, clearing away heat and cooling blood, promoting blood circulation and detoxication, Radix Curcumae master enters the heart, Liver Channel, promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, it is equipped with Radix Et Rhizoma Nardostachyos damp eliminating detumescence, alleviating the other medicines sensitivity response to skin, this subsidiary formula 2 is share with main formula, relatively treatment vitiligo mid-term, depressed emotion, liver imbalance is smooth, qi-blood disharmony, caused by failure of skin and muscle to be nourished.
8. main formula adds subsidiary formula 2 clinical trial
With reference to the criterion of therapeutical effect of " clinical disease diagnosis is according to curing improvement standard " (the Sun Chuanxing work People's Medical Officer Press second edition), the concrete curative effect of this liniment is divided into following three grades: cure: skin color recovers normal completely, does not recur; Effective: to have pigment island to be formed in white macula skin lesion, skin color 80% recovers normal, occurs without recurrence and new rash; Take a turn for the better: having pigment island to be formed in white macula skin lesion, skin color 50% recovers normal, occur without recurrence and new rash; Invalid: vitiligo symptom has no to disappear, and white macula is not any change.
Since 2013, in local multiple hospitals, when patient is voluntary, extract patient 92 example, wherein course of disease patient 32 example within 3 months, is ill initial stage, the course of disease patient of 3 months to 2 years 30 example, it is ill mid-term, 30 examples of the course of disease more than 2 years, is the ill later stage. Medication 15 days is a course for the treatment of, all three courses for the treatment of of treatment, and its result is added up such as table 3:
Table 3
Upper table data are visible: the overall clinical efficacy rate in mid-term apparently higher than initial stage, later stage, illustrates that main formula adds subsidiary formula 2 and course of disease patient in mid-term between 3 months to 2 years is acted on substantially.
9. the subsidiary formula 3 crude drug property of medicine is analyzed:
Pit mongolian medicine name awns accuses day Ji wood this " errorless mongolian medicine mirror ", and different name Ah bar comes, " errorless mongolian medicine mirror " is come in Sabah. Pit for Anacardiaceae plant fruit MangiferaindicaL.. Fruit contains myrcene, fruit keto acid, gallic acid, Quercetin, vitamin C, glucose etc. The property of medicine: sour in the mouth, sweet, warm in nature. Effect is heavy, greasy, returns kidney channel. Function cures mainly: the kidney invigorating, renal cold of dispelling. Cure mainly and suffer from a deficiency of the kidney, renal cold, lumbago and skelalgia.
Fructus Alpiniae Oxyphyllae is the dry mature fruit of zingiberaceous plant Fructus Alpiniae Oxyphyllae. Nature and flavor: pungent, temperature. Return spleen, kidney channel. Function with cure mainly: warming the kidney controlling nocturnal emission with astringent drugs reducing urination, warming spleen and stopping diarrha take the photograph saliva. For enuresis due to deficiency of the kidney, frequent micturition, nebulousurine of passing out semen, spleen-cold syndrome is had loose bowels, cold type of pain in abdomen, the many salivas of mouth.
My Tan Qiqige, not Dege Si Qin of Flos Trollii mongolian medicine name, my smooth Flos Nelumbinis, pentahapto Xi Laqiqige. Dried floral for ranunculaceae plant Flos Trollii TrolliuschinensisBunge. Nature and flavor: bitter in the mouth, cold in nature, blunt, light, soft. There are heat clearing away, dry pus, convergence, effect of Perishing prevention.
Visible, above-mentioned three taste medicines, pit nature and flavor are sour, warm, and Fructus Alpiniae Oxyphyllae nature and flavor are pungent, warm, all enter kidney channel, synergism, temperature compensation kidney, are equipped with Flos Trollii heat clearing away, dry pus, convergence, Perishing prevention, alleviate the other medicines sensitivity response to skin. This subsidiary formula 3 is share with main formula, relatively the treatment vitiligo later stage, and owing to the primary disease persistent period is permanent, prolonged illness damages, and causes caused by caused by liver and kidney deficiency.
10. main formula adds subsidiary formula 3 clinical trial
With reference to the criterion of therapeutical effect of " clinical disease diagnosis is according to curing improvement standard " (the Sun Chuanxing work People's Medical Officer Press second edition), the concrete curative effect of this liniment is divided into following three grades: cure: skin color recovers normal completely, does not recur; Effective: to have pigment island to be formed in white macula skin lesion, skin color 80% recovers normal, occurs without recurrence and new rash; Take a turn for the better: having pigment island to be formed in white macula skin lesion, skin color 50% recovers normal, occur without recurrence and new rash; Invalid: vitiligo symptom has no to disappear, and white macula is not any change.
Since 2014, in local multiple hospitals, when patient is voluntary, extract patient 95 example, wherein course of disease patient 32 example within 3 months, is ill initial stage, the course of disease patient of 3 months to 2 years 32 example, it is ill mid-term, 31 examples of the course of disease more than 2 years, is the ill later stage. Medication 15 days is a course for the treatment of, all three courses for the treatment of of treatment, and its result is added up such as table 4:
Table 4
Upper table data are visible: the overall clinical efficacy rate in later stage, apparently higher than initial stage, mid-term, illustrates that main formula adds subsidiary formula 3 and the later stage patient that the course of disease is longer is acted on substantially.
Claims (8)
1. treat leukodermic Traditional Chinese medicine liniment for one kind, it is characterised in that: described Traditional Chinese medicine liniment is made up of the crude drug of following weight portion: Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae.
2. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 1, it is characterised in that: described Traditional Chinese medicine liniment preparation method is: the crude drug of said ratio amount was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add the alcoholic solution that crude drug volume 10 times amount, concentration are 25% 30%, cover bottle cap sealing, soak 3, filter to obtain filtrate, residue squeezes to obtain pressed liquor, and pressed liquor merges with filtrate, stands 24 hours, take the supernatant, obtain liniment.
3. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 1, it is characterised in that: described crude drug adds Radix Sophorae Flavescentis 58 parts, Cortex Phellodendri 46 parts, Fructus Chaenomelis 34 parts.
4. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 3, it is characterized in that: the preparation method of above-mentioned Traditional Chinese medicine liniment is: by Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, Radix Sophorae Flavescentis 58 parts, Cortex Phellodendri 46 parts, Fructus Chaenomelis 34 parts, it was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add said medicine volume 10 times amount, concentration is the alcoholic solution of 25% 30%, cover bottle cap sealing, soak 3, filter to obtain filtrate, residue squeezes to obtain pressed liquor, pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
5. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 1, it is characterised in that: described crude drug adds Radix Arnebiae (Radix Lithospermi) 57 parts, Radix Curcumae 36 parts, Radix Et Rhizoma Nardostachyos 25 parts.
6. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 5, it is characterized in that: the preparation method of above-mentioned Traditional Chinese medicine liniment is: by Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, Radix Arnebiae (Radix Lithospermi) 57 parts, Radix Curcumae 36 parts, Radix Et Rhizoma Nardostachyos 25 parts, it was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add said medicine volume 10 times amount, concentration is the alcoholic solution of 25% 30%, cover bottle cap sealing, soak 3, filter to obtain filtrate, residue squeezes to obtain pressed liquor, pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
7. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 1, it is characterised in that: described crude drug adds pit 47 parts, Fructus Alpiniae Oxyphyllae 35 parts, Flos Trollii 35 parts.
8. the leukodermic Traditional Chinese medicine liniment for the treatment of according to claim 7, it is characterized in that: the preparation method of above-mentioned Traditional Chinese medicine liniment is: by Fructus Tribuli 18 30 parts, Fructus Psoraleae 9 18 parts, Radix Polygoni Multiflori Preparata 8 12 parts, Radix Angelicae Sinensis 6 15 parts, 26 parts of Flos Carthami, 2 10 parts of Radix Glycyrrhizae, pit 47 parts, Fructus Alpiniae Oxyphyllae 35 parts, Flos Trollii 35 parts, it was ground into the fine powder of 100 mesh sieves, Homogeneous phase mixing, load in vial, add said medicine volume 10 times amount, concentration is the alcoholic solution of 25% 30%, cover bottle cap sealing, soak 3, filter to obtain filtrate, residue squeezes to obtain pressed liquor, pressed liquor merges with filtrate, stand 24 hours, take the supernatant, obtain liniment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610034184.2A CN105616536A (en) | 2016-01-18 | 2016-01-18 | Traditional Chinese medicine liniment for treating leukoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610034184.2A CN105616536A (en) | 2016-01-18 | 2016-01-18 | Traditional Chinese medicine liniment for treating leukoderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105616536A true CN105616536A (en) | 2016-06-01 |
Family
ID=56032153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610034184.2A Pending CN105616536A (en) | 2016-01-18 | 2016-01-18 | Traditional Chinese medicine liniment for treating leukoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105616536A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260877A (en) * | 2017-06-26 | 2017-10-20 | 刘骞 | One kind disappears white antibacterial aqua |
| CN107485649A (en) * | 2017-09-05 | 2017-12-19 | 李太平 | A kind of formula for treating leucoderma and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1315186A (en) * | 2000-03-30 | 2001-10-03 | 陈江辉 | Medical tea for treating leukoderma and its preparing process |
| CN101057922A (en) * | 2007-05-16 | 2007-10-24 | 长春同春堂皮肤病医院 | Traditional Chinese medicine preparation for treating vitiligo |
| CN101496844A (en) * | 2009-03-19 | 2009-08-05 | 董娜 | External preparation for treating leukoderma and method for preparing and using the same |
| CN101664436A (en) * | 2008-09-04 | 2010-03-10 | 谭汉卿 | Chinese medicinal liniment for treating vitiligo |
| CN101711732A (en) * | 2009-11-19 | 2010-05-26 | 李振彬 | Externally-applied traditional Chinese medicine preparation for treating leukoderma |
| CN103169776A (en) * | 2013-01-25 | 2013-06-26 | 山东中医药大学附属医院 | External medicament for treating leucoderma and preparation method thereof |
| CN103655739A (en) * | 2012-09-18 | 2014-03-26 | 青岛医防消毒专业技术中心 | Plant-source anti-leucoderma compound spray |
-
2016
- 2016-01-18 CN CN201610034184.2A patent/CN105616536A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1315186A (en) * | 2000-03-30 | 2001-10-03 | 陈江辉 | Medical tea for treating leukoderma and its preparing process |
| CN101057922A (en) * | 2007-05-16 | 2007-10-24 | 长春同春堂皮肤病医院 | Traditional Chinese medicine preparation for treating vitiligo |
| CN101664436A (en) * | 2008-09-04 | 2010-03-10 | 谭汉卿 | Chinese medicinal liniment for treating vitiligo |
| CN101496844A (en) * | 2009-03-19 | 2009-08-05 | 董娜 | External preparation for treating leukoderma and method for preparing and using the same |
| CN101711732A (en) * | 2009-11-19 | 2010-05-26 | 李振彬 | Externally-applied traditional Chinese medicine preparation for treating leukoderma |
| CN103655739A (en) * | 2012-09-18 | 2014-03-26 | 青岛医防消毒专业技术中心 | Plant-source anti-leucoderma compound spray |
| CN103169776A (en) * | 2013-01-25 | 2013-06-26 | 山东中医药大学附属医院 | External medicament for treating leucoderma and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 向阳，向云飞编著: "《灸者健康之长寿美颜》", 30 November 2014, 中国医药科技出版社 * |
| 季素珍主编: "《漫话白癜风》", 30 April 2013, 中国医药科技出版社 * |
| 李秀敏/段行武主编: "《当代中医皮肤科临床家丛书》", 30 September 2015, 中国医药科技出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260877A (en) * | 2017-06-26 | 2017-10-20 | 刘骞 | One kind disappears white antibacterial aqua |
| CN107485649A (en) * | 2017-09-05 | 2017-12-19 | 李太平 | A kind of formula for treating leucoderma and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
| CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
| CN102091203A (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN103751633A (en) | Traditional Chinese medicinal composition for treating varicose vein of lower limb and preparation method thereof | |
| CN101518600B (en) | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof | |
| CN104740458A (en) | Pruritus treating traditional Chinese medicine composition | |
| CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
| CN102178877B (en) | External preparation for treating eczema of scrotum and preparation method thereof | |
| CN102000164A (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN103705751A (en) | Traditional Chinese medicine composition for treating rheumatic lumbago and preparation method thereof | |
| CN103877247A (en) | Medicine for treating bedsore and preparation method thereof | |
| CN110840978A (en) | A Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis, and medicated liquor containing the same | |
| CN104740583A (en) | Traditional Chinese medicine preparation for relieving Crohn's disease and preparation method for traditional Chinese medicine preparation | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN104784346A (en) | Pruritus treating traditional Chinese medicine lotion preparation method | |
| CN103656048B (en) | Medicine being used for the treatment of mammitis of cow and preparation method thereof | |
| CN105616536A (en) | Traditional Chinese medicine liniment for treating leukoderma | |
| CN104940886A (en) | External preparation for treating seborrheic alopecia and preparing method thereof | |
| CN105106749A (en) | Traditional Chinese medicinal composition for haemorrhoids treatment in general surgery departments | |
| CN103721138A (en) | External traditional Chinese medicinal preparation for treating acne rosacea and preparation method thereof | |
| CN103054991B (en) | Traditional Chinese medicine composition for treating lower abdominal discomfort, as well as preparation method and use thereof | |
| CN104127737A (en) | Pharmaceutical composition for preventing and treating postoperative complications of haemorrhoids and preparation method of pharmaceutical composition | |
| CN103989969A (en) | Traditional Chinese medicament for treating wind-cold obstruction type cervical spondylotic radiculopathy and preparation method thereof | |
| CN105663585A (en) | Application of traditional Chinese medicine composition in preparation of medicines for treating senile pruritus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160601 |